1. Home
  2. SONN vs NUWE Comparison

SONN vs NUWE Comparison

Compare SONN & NUWE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SONN
  • NUWE
  • Stock Information
  • Founded
  • SONN N/A
  • NUWE 1999
  • Country
  • SONN United States
  • NUWE United States
  • Employees
  • SONN N/A
  • NUWE N/A
  • Industry
  • SONN Biotechnology: Pharmaceutical Preparations
  • NUWE Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • SONN Health Care
  • NUWE Health Care
  • Exchange
  • SONN Nasdaq
  • NUWE Nasdaq
  • Market Cap
  • SONN 3.3M
  • NUWE 2.8M
  • IPO Year
  • SONN N/A
  • NUWE N/A
  • Fundamental
  • Price
  • SONN $2.98
  • NUWE $1.21
  • Analyst Decision
  • SONN Strong Buy
  • NUWE Strong Buy
  • Analyst Count
  • SONN 3
  • NUWE 1
  • Target Price
  • SONN $117.33
  • NUWE $17.00
  • AVG Volume (30 Days)
  • SONN 1.4M
  • NUWE 7.1M
  • Earning Date
  • SONN 12-12-2024
  • NUWE 11-11-2024
  • Dividend Yield
  • SONN N/A
  • NUWE N/A
  • EPS Growth
  • SONN N/A
  • NUWE N/A
  • EPS
  • SONN N/A
  • NUWE N/A
  • Revenue
  • SONN $55,881.00
  • NUWE $8,969,000.00
  • Revenue This Year
  • SONN N/A
  • NUWE $3.23
  • Revenue Next Year
  • SONN N/A
  • NUWE $17.61
  • P/E Ratio
  • SONN N/A
  • NUWE N/A
  • Revenue Growth
  • SONN N/A
  • NUWE 3.66
  • 52 Week Low
  • SONN $2.50
  • NUWE $1.00
  • 52 Week High
  • SONN $18.72
  • NUWE $31.15
  • Technical
  • Relative Strength Index (RSI)
  • SONN 30.17
  • NUWE 41.93
  • Support Level
  • SONN $2.50
  • NUWE $1.28
  • Resistance Level
  • SONN $3.50
  • NUWE $1.96
  • Average True Range (ATR)
  • SONN 0.85
  • NUWE 0.33
  • MACD
  • SONN 0.00
  • NUWE -0.09
  • Stochastic Oscillator
  • SONN 6.38
  • NUWE 2.16

About SONN Sonnet BioTherapeutics Holdings Inc.

Sonnet BioTherapeutics Holdings Inc is a clinical-stage biotechnology company. The company has developed FHAB (Fully Human Albumin Binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory, and hematological conditions. The firm's pipeline products include SON-080 (low-dose IL-6), SON-1210 (IL15- FHAB-IL12), SON-1010 (IL12-FHAB), and others.

About NUWE Nuwellis Inc.

Nuwellis Inc is a medical device company. Its solutions includes Aquadex Smartflow System and RenalSense Clarity RMS. The Aquadex Smartflow System removes excess fluid from patients suffering from fluid overload who have not responded to medical management, including diuretics. Clarity RMS is a kidney monitoring system that continuously measures urine output and flows, automatically displaying real-time data to the medical staff.

Share on Social Networks: